Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,467,211 papers from all fields of science
Search
Sign In
Create Free Account
Seneca Valley Virus-001
Known as:
NTX-010
, SVV-001
A replication-competent oncolytic picornavirus with potential antineoplastic activity. Administered systemically, Seneca Valley virus-001…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract 706: Combination ionizing radiation and oncolytic Seneca Valley virus injection enhances tumor cell killing of pediatric gliomas
Yuchen Du
2017
Corpus ID: 90780023
Background and Purpose: Radiation therapy is the traditional and only therapy that offers benefits to patients with diffuse…
Expand
2016
2016
EXTH-49. INTRAVENOUS INJECTION OF ONCOLYTIC PICORNAVIRUS SVV-001 PROLONGS ANIMAL SURVIVAL IN A NOVELPANEL OF PATIENT-DERIVED ORTHOTOPIC XENOGRAFT MOUSE MODELS OF ADULT GLIOBLASTOMA
Huiyuan Zhang
,
Yuchen Du
,
+10 authors
Xiao-Nan Li
2016
Corpus ID: 78415086
2016
2016
Abstract 4390: SVV-001 prolongs animal survival in PDOX adult GBM models
Huiyuan Zhang
,
Lin Qi
,
+9 authors
Xiao-Nan Li
2016
Corpus ID: 78159789
Background: Glioblastoma (GBM) is the most malignant and aggressive brain tumor, and survival of patients affected by GBM has…
Expand
2014
2014
413 Next-generation sequencing identifies the mechanism of tumourigenesis caused by loss of SMARCB1 in malignant rhabdoid tumours
M. Finetti
,
M. Selby
,
+7 authors
D. Williamson
2014
Corpus ID: 56917599
Review
2013
Review
2013
A randomized double-blind phase II study of the Seneca Valley virus (NTX-010) versus placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least four cycles…
J. Molina
,
S. Mandrekar
,
+10 authors
A. Adjei
2013
Corpus ID: 78611372
7509 Background: NTX-010 is a naturally occurring replication-competent picornavirus with potent and selective tropism for SCLC…
Expand
2010
2010
Abstract 4185: Isolation of cancer stem-like cells from a novel orthotopic xenograt model of supratentorial primitive neuroectodermal tumor that is susceptible to oncolytic Seneca Valley Virus
Zhigang Liu
,
Xiumei Zhao
,
+10 authors
Xiao-Nan Li
2010
Corpus ID: 72719260
Purpose: Supratentorial primitive neuroectodermal tumor (PNET) accounts for 2-3% of all pediatric brain tumors. Despite…
Expand
2009
2009
Phase I study of intravenous Seneca Valley virus (NTX-010), a replication competent oncolytic virus, in patients with neuroendocrine (NE) cancers.
C. Rudin
,
N. Senzer
,
+4 authors
P. Hallenbeck
Journal of Clinical Oncology
2009
Corpus ID: 30759538
4629 Background: NTX-010 is a naturally occurring replication competent picornavirus with potent and selective tropism for human…
Expand
2008
2008
191 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the oncolytic picornavirus, NTX-010 (SVV-001)
C. Morton
,
P. Houghton
,
+5 authors
Malcolm A. Smith
2008
Corpus ID: 72117366
2007
2007
Phase I trial of Seneca Valley Virus (NTX-010), a newly discovered systemically deliverable oncolytic picornavirus, in patients with solid tumors with neuroendocrine features
C. Rudin
,
D. Lansey
,
+4 authors
P. Hallenbeck
2007
Corpus ID: 74736617
18014 Background: NTX-010 is a replication-competent cytolytic picornavirus with selective tropism for cancers with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required